SMTL ID : 4p38.2 (1 other biounit)

Human 11beta-Hydroxysteroid Dehydrogenase Type 1 in complex with AZD8329

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.80 Å

Oligo State

homo-tetramer

Ligands

4 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NDP.1: 30 residues within 4Å: Chain A: G.16, A.17, S.18, K.19, G.20, I.21, A.40, R.41, S.42, G.66, T.67, M.68, N.94, H.95, I.96, N.98, V.117, V.143, S.144, S.145, Y.158, K.162, L.190, G.191, L.192, I.193, T.195, T.197, A.198 Ligands: 21T.2 19 PLIP interactions: 19 interactions with chain A Hydrogen bonds: A:G.16, A:S.18, A:S.18, A:S.18, A:K.19, A:I.21, A:R.41, A:S.42, A:T.67, A:T.67, A:M.68, A:N.94, A:Y.122, A:K.162, A:I.193, A:T.195 Salt bridges: A:K.19, A:K.19, A:R.41 NDP.4: 30 residues within 4Å: Chain B: G.16, A.17, S.18, K.19, G.20, I.21, A.40, R.41, S.42, G.66, T.67, M.68, N.94, H.95, I.96, N.98, Y.122, V.143, S.144, S.145, Y.158, K.162, L.190, G.191, L.192, I.193, T.195, T.197, A.198 Ligands: 21T.5 26 PLIP interactions: 26 interactions with chain B Hydrophobic interactions: B:L.190 Hydrogen bonds: B:S.18, B:S.18, B:K.19, B:K.19, B:I.21, B:R.41, B:S.42, B:T.67, B:T.67, B:M.68, B:N.94, B:N.94, B:I.96, B:N.98, B:Y.122, B:K.162, B:I.193, B:T.195, B:T.195, B:T.197 Water bridges: B:G.22, B:T.197 Salt bridges: B:K.19, B:K.19, B:R.41 NDP.7: 30 residues within 4Å: Chain C: G.16, A.17, S.18, K.19, G.20, I.21, A.40, R.41, S.42, G.66, T.67, M.68, N.94, H.95, I.96, N.98, V.117, V.143, S.144, S.145, Y.158, K.162, L.190, G.191, L.192, I.193, T.195, T.197, A.198 Ligands: 21T.8 21 PLIP interactions: 21 interactions with chain C Hydrogen bonds: C:G.16, C:S.18, C:S.18, C:S.18, C:K.19, C:I.21, C:R.41, C:S.42, C:T.67, C:M.68, C:N.94, C:N.98, C:Y.158, C:K.162, C:I.193, C:T.195, C:T.195, C:T.197 Salt bridges: C:K.19, C:K.19, C:R.41 NDP.10: 30 residues within 4Å: Chain D: G.16, A.17, S.18, K.19, G.20, I.21, A.40, R.41, S.42, G.66, T.67, M.68, N.94, H.95, I.96, N.98, Y.122, V.143, S.144, S.145, Y.158, K.162, L.190, G.191, L.192, I.193, T.195, T.197, A.198 Ligands: 21T.11 24 PLIP interactions: 24 interactions with chain D Hydrophobic interactions: D:L.190 Hydrogen bonds: D:S.18, D:S.18, D:K.19, D:K.19, D:I.21, D:R.41, D:S.42, D:T.67, D:M.68, D:N.94, D:N.94, D:I.96, D:N.98, D:Y.158, D:K.162, D:I.193, D:T.195 Water bridges: D:G.22, D:T.97, D:T.197 Salt bridges: D:K.19, D:K.19, D:R.41

4 x 21T: 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic acid(Non-covalent)

21T.2: 15 residues within 4Å: Chain A: L.101, S.145, L.146, Y.152, V.155, Y.158, L.190, G.191, L.192, A.198, A.201, M.208 Chain B: Y.255, Y.259 Ligands: NDP.1 14 PLIP interactions: 11 interactions with chain A, 3 interactions with chain B Hydrophobic interactions: A:L.101, A:L.146, A:Y.152, A:V.155, A:V.155, A:L.192, A:L.192, A:A.198, A:A.201, B:Y.255, B:Y.255 Hydrogen bonds: A:S.145, A:Y.158 Water bridges: B:S.258 21T.5: 16 residues within 4Å: Chain A: Y.255, Y.259 Chain B: T.99, L.101, S.145, L.146, Y.152, V.155, Y.158, L.190, G.191, L.192, A.198, A.201, M.208 Ligands: NDP.4 16 PLIP interactions: 13 interactions with chain B, 3 interactions with chain A Hydrophobic interactions: B:L.101, B:L.146, B:Y.152, B:V.155, B:V.155, B:Y.158, B:Y.158, B:L.192, B:L.192, B:A.198, B:A.201, A:Y.255 Hydrogen bonds: B:S.145, B:Y.158, A:Y.259 Water bridges: A:Y.255 21T.8: 15 residues within 4Å: Chain C: L.101, S.145, L.146, Y.152, V.155, Y.158, L.190, G.191, L.192, A.198, A.201, M.208 Chain D: Y.255, Y.259 Ligands: NDP.7 14 PLIP interactions: 10 interactions with chain C, 4 interactions with chain D Hydrophobic interactions: C:L.101, C:L.146, C:Y.152, C:V.155, C:V.155, C:L.192, C:L.192, C:A.198, C:A.201, D:Y.255, D:Y.255 Hydrogen bonds: C:S.145, D:Y.259 Water bridges: D:S.258 21T.11: 16 residues within 4Å: Chain C: Y.255, Y.259 Chain D: T.99, L.101, S.145, L.146, Y.152, V.155, Y.158, L.190, G.191, L.192, A.198, A.201, M.208 Ligands: NDP.10 14 PLIP interactions: 12 interactions with chain D, 2 interactions with chain C Hydrophobic interactions: D:L.101, D:L.146, D:Y.152, D:V.155, D:V.155, D:Y.158, D:Y.158, D:L.192, D:L.192, D:A.198, D:A.201, C:Y.255 Hydrogen bonds: D:S.145 Water bridges: C:Y.255

4 x CL: CHLORIDE ION(Non-functional Binders)

CL.3: 5 residues within 4Å: Chain A: G.20, R.23, T.195, E.196, K.213 Ligand excluded by PLIP CL.6: 4 residues within 4Å: Chain B: G.20, T.195, E.196, K.213 Ligand excluded by PLIP CL.9: 5 residues within 4Å: Chain C: G.20, R.23, T.195, E.196, K.213 Ligand excluded by PLIP CL.12: 4 residues within 4Å: Chain D: G.20, T.195, E.196, K.213 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Scott, J.S. et al., Novel acidic 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) inhibitor with reduced acyl glucuronide liability: the discovery of 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic acid (AZD8329). J.Med.Chem. (2012)

Release Date

2014-04-30

Peptides

Corticosteroid 11-beta-dehydrogenase isozyme 1: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
A

D
B

Corticosteroid 11-beta-dehydrogenase isozyme 1

Related Entries With Identical Sequence